DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

INSMED, INC. (NASDAQ: INSM)

14.89 0.30 (2.06%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INSM $14.89 2.06%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.60
Previous Close $14.59
Daily Range $14.40 - $15.00
52-Week Range $11.25 - $21.33
Market Cap $739.5M
P/E Ratio -7.64
Dividend (Yield) $0.00 (0.0%)
Volume 281,294
Average Daily Volume 517,870
Current FY EPS -$2.07

Sector

Healthcare

Industry

Drugs

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website: http://www.insmed.com/

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape

Markets Rise; Macy's Lowers Comparable Sales Outlook

Markets Rise; Macy's Lowers Comparable Sales Outlook

Benzinga's Volume Movers

Sector Update: Health Care

See More INSM News...

INSM's Top Competitors

INSM $14.89 (2.06%)
Current stock: INSM
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB